she fell down 3 times; Arteriosclerosis; Coronary Artery Disease; Post-covid syndrome; She was down to 99 lbs.; Pain in back of her neck; She had no energy; She was experiencing dizziness that started 1 week after receiving 1st dose/In 3rd week, dizziness got worst; She had stomach pain; She started experiencing headache after 1 week/Sharp pain in her head that would come and go; Nausea; Injection site started itching after 3-4 days; It was red from injection site down to the elbow.; Her left arm was sore for a week; This spontaneous case was reported by a patient and describes the occurrence of ARTERIOSCLEROSIS (Arteriosclerosis), CORONARY ARTERY DISEASE (Coronary Artery Disease), POST-ACUTE COVID-19 SYNDROME (Post-covid syndrome), WEIGHT DECREASED (She was down to 99 lbs.) and NECK PAIN (Pain in back of her neck) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN, PAROXETINE, ATORVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced MYALGIA (Her left arm was sore for a week). On 04-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site started itching after 3-4 days) and VACCINATION SITE ERYTHEMA (It was red from injection site down to the elbow.). On 07-Apr-2021, the patient experienced NECK PAIN (Pain in back of her neck), ASTHENIA (She had no energy), DIZZINESS (She was experiencing dizziness that started 1 week after receiving 1st dose/In 3rd week, dizziness got worst), ABDOMINAL PAIN UPPER (She had stomach pain), HEADACHE (She started experiencing headache after 1 week/Sharp pain in her head that would come and go) and NAUSEA (Nausea). On 03-May-2021, the patient experienced ARTERIOSCLEROSIS (Arteriosclerosis), CORONARY ARTERY DISEASE (Coronary Artery Disease), POST-ACUTE COVID-19 SYNDROME (Post-covid syndrome) and WEIGHT DECREASED (She was down to 99 lbs.). On an unknown date, the patient experienced FALL (she fell down 3 times). The patient was treated with MECLOZINE HYDROCHLORIDE (ANTIVERT [MECLOZINE HYDROCHLORIDE]) at an unspecified dose and frequency and PANTOPRAZOLE at an unspecified dose and frequency. At the time of the report, ARTERIOSCLEROSIS (Arteriosclerosis), CORONARY ARTERY DISEASE (Coronary Artery Disease), POST-ACUTE COVID-19 SYNDROME (Post-covid syndrome), WEIGHT DECREASED (She was down to 99 lbs.), NECK PAIN (Pain in back of her neck), ASTHENIA (She had no energy), DIZZINESS (She was experiencing dizziness that started 1 week after receiving 1st dose/In 3rd week, dizziness got worst), ABDOMINAL PAIN UPPER (She had stomach pain), FALL (she fell down 3 times), VACCINATION SITE PRURITUS (Injection site started itching after 3-4 days), MYALGIA (Her left arm was sore for a week), VACCINATION SITE ERYTHEMA (It was red from injection site down to the elbow.), HEADACHE (She started experiencing headache after 1 week/Sharp pain in her head that would come and go) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, Blood potassium: high High. On 03-May-2021, Blood sodium: low Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's liver enzymes were elevated